Complementary program

Complementary program June 28-30, 2018

The Complementary program´s sessions will be in room C1-C3 located on level 2

28TH OF JUNE - THURSDAY - LOCATED IN ROOM C1-C3 on level 2

Time     Complementary program
11111111  
Main topic of the day: Inflammatory disease – a new way of thinking, a new way of treating
jjjjj
10.00-10.10Introduction to complementary program  
Hoseah Waweru
jjjj
10.10-11.00Symposium: Inflammation in psoriasis and psoriatic arthritis      
The inflammatory process and its impact on the body
Lars Iversen
A multi-disciplinary approach to treating inflammation in psoriasis and psoriatic arthritis
Joseph Merola
Q & A session with speakers
jjjjjj
11.00-11.10Break
m
11.10-12.00Symposium continued: Inflammation in psoriasis and psoriatic arthritis
Genotype vs Phenotype of psoriatic disease, insights to alter its care & management
Gerald Krueger
New and future therapies – understanding how we treat inflammatory disease today, tomorrow and beyond
Kilian Eyerich
Q & A session with speakers

29TH OF JUNE - FRIDAY - LOCATED IN ROOM C1-C3 on level 2

Time Agenda
m
07.3  Main topic of the day: Patient-centered care: what is it and what is needed?
 
10.00-11.00            Symposium: Patient-centricity – from the laboratory to the clinic
Patient involvement in research
Maarten de Wit
Promoting patient-centered care in psoriatic arthritis
Neil Betteridge
Treatment targets and patient reported outcomes measures – promoting patient inclusivity
Ulrich Mroweietz
jjjj
11.00-11.10 Break
jjjj
11.10-11.55 Symposium: Patient-centered care- seeing to the needs of the whole patient
An integrative approach to psoriasis and its comorbid conditions
Francisco Tausk
The Stockholm treatment centres- a model for treatment on the patient’s terms
Lars Ettarp, Gunnel Köhler
Q & A session with speakers
11.55-12.05 The Swedish HTA report on systemic treatment and UV treatment for Psoriasis

 

30TH OF JUNE - SATURDAY - LOCATED IN ROOM C1-C3 on level 2

Time Agenda
m
07.30-08.00       Main topic of the day: Improving quality of life – from managing itch to minimizing adverse events
 
10.00-11.00          Symposium: Quality of Life issues in psoriasis and psoriatic arthritis
Itch management in psoriasis
Gil Yosipovitch
Psychosocial issues connected to psoriasis and psoriatic arthritis
Florence Dalgard
Psoriasis and sexual dysfunction
Grigorios Theodosiou
Panel discussion and Q & A session
jjjjjjjjjj
11.00-11.10 Break
jjjjjjj
11.10-11.55 Symposium: Patient safety management – the responsibility of the doctor, the patient and the patient organizations
Adherence and safety issues in treatment – improving outcomes through better communication
Abby Van Voorhees
Biosimilars – what the patients need to know and the patient organizations take action on
Eva Maria Ruiz del Castilla
Discussion: promoting a safer and healthier future for all people with psoriasis and psoriatic arthritis
jjjj
11.55-12.00 Closing remarks

The International Federation of Psoriasis Associations is a non-profit organization representing over 125 million people living with psoriasis or psoriatic arthritis worldwide.

IFPA Secretariat
Gustavslundsvägen 143
167 51 Bromma, SWEDEN